COVID-19 in patients with chronic kidney disease stage 5

  • I. Dudar Kyiv City Center of Nephrology and Dialysis https://orcid.org/0000-0002-4372-8240
  • E. Krasyuk Kyiv City Center of Nephrology and Dialysis
  • A. Shymova Kyiv City Center of Nephrology and Dialysis
  • Y. Hryhorieva Kyiv City Center of Nephrology and Dialysis
  • M. Malasaiev Kyiv City Center of Nephrology and Dialysis
  • O. Fierients Kyiv City Center of Nephrology and Dialysis
  • І. Shifris SI “Institute of Nephrology NAMS of Ukraine” https://orcid.org/0000-0002-9413-7301
  • V. Savchuk Kyiv City Center of Nephrology and Dialysis
  • І. Burzhynska Kyiv City Center of Nephrology and Dialysis
  • F. Prusskyi Kyiv City Center of Nephrology and Dialysis
Keywords: coronavirus disease, chronic kidney disease, renal replacement therapy, hemodialysis, peritoneal dialysis, diabetes, obesity, survival.

Abstract

The study aimed to determine the frequency of COVID-19, specific of process and the mortality rate among dialysis patients with COVID-19.

Materials and methods: The retrospective study included 764 patients with CKD VD, who received dialysis treatment at the Kyiv City Center for Nephrology and Dialysis, which is the clinical base of the Institute of Nephrology of the National Academy of  Medical  Sciences since September 1, 2020. until December 31, 2020. 155 patients were diagnosed with coronavirus disease. The study was conducted in two stages. In the first stage, dialysis patients with coronavirus disease were divided into groups depending on the severity of the disease.

The second stage of the study was determined the influence of age, duration of dialysis treatment, gender, cause of chronic kidney disease VD, obesity, diabetes mellitus and cardiovascular pathology on the course of coronavirus disease, as well as complications and mortality from COVID-19  among the dialysis population.

Results: 155 cases of COVID-19 were registered among 764 dialysis patients. Mild coronavirus disease was diagnosed in 38 (24.5%) patients, moderate and severe in 64 (41.3%) and 53 (34.2%) patients, respectively. Oxygen support was required for 76 patients (79%), and artificial lung ventilation was used for 17 (10.9%) patients. Factors associated with severe coronavirus disease in this category of patients were found to be obesity (BMI> 30 kg / m2), diabetes mellitus, concomitant cardiovascular disease, and the need for oxygen support.  In this category of patients, obesity (BMI>30 kg/m2), cardiovascular disease, diabetes mellitus and require supplement oxygen are associated with severe Coronavirus disease COVID-19. There was no significant effect on the severity of coronavirus disease in the age of patients and duration of dialysis treatment. The duration of treatment in patients with diabetes was significantly higher (p <0.05), a direct strong correlation between BMI and duration of treatment was demonstrated.

Survival was significantly higher in the group of patients who did not require oxygen support (78% vs. 56%) and had a BMI <30 kg / m2 (87% vs. 37%).

Conclusions: the incidence of coronavirus disease among the dialysis cohort was 20.2% of cases. Patients treated with peritoneal dialysis had a significantly lower incidence. Severe coronavirus disease has been associated with obesity, cardiovascular disease, and the need for oxygen support. Men were more likely to have COVID-19 than women. There is no connection between the severe course of coronavirus disease with the age of patients and the duration of dialysis treatment. The duration of treatment of Coronavirus disease in the group of patients with diabetes and high BMI was longer. The following complications predominated in patients with COVID-19: thrombosis of arteriovenous fistula and atrial fibrillation. 

During the study period, 20 (12.9%) deaths were registered. Patient survival was higher in the group of patients without oxygen support and with a lower BMI.

Downloads

Download data is not yet available.

References

Kolesnyk MO. Natsionalnyi reiestr khvorykh na khronichnu khvorobu nyrok ta patsiientiv z hostrym poshkodzhenniam nyrok: 2019 rik. Kyiv; 2018. 183 s. [In Ukrainian].

Nancy A. Melville. Nephrologists on Lessons Learned With Kidney Disease in CОVID-19. Medscape. (Accessed April 08, 2020). Available from: https://www.medscape.com/viewarticle/928346.

Levey AS, Eckardt KU, Dorman NM, Christiansen SL, Hoorn EJ, Ingelfinger JR, Inker LA, Levin A, Mehrotra R, Palevsky PM, et al. Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int. 2020;97(6):1117-1129. doi: 10.1016/j.kint.2020.02.010.

Naicker S, Yang CW, Hwang SJ, Liu BC, Chen JH, Jha V.  The Novel Coronavirus 2019 Epidemic and Kidneys. Kidney International. 2020;97(5):824-828. doi: 10.1016/j.kint.2020.03.001.

La Milia V, Bacchini G, Bigi MC et al. COVID-19 outbreak in a large hemodialysis center in Lombardy, Italy. Kidney Int Rep 2020; 5: 1095–1099. doi: 10.1016/j.ekir.2020.05.019

Stock da Cunha T, Gomá-Garcés E, Avello A, Pereira-García M, Mas-Fontao S, Ortiz A, González-Parra E. The Spectrum of Clinical and Serological Features of COVID-19 in Urban Hemodialysis Patients. J Clin Med. 2020;9(7):2264. doi: 10.3390/jcm9072264.

Lano G, Braconnier A, Bataille S, Cavaille G, Moussi-Frances J, Gondouin B, et al. Risk factors for severity of COVID-19 in chronic dialysis patients from a multicentre French cohort. Clin Kidney J. 2020;13(5):878-888. doi: 10.1093/ckj/sfaa199.

Yau K, Muller MP, Lin M, Siddiqui N, Neskovic S, Shokar G, Fattouh R, Matukas LM, Beaubien-Souligny W, Thomas A, Weinstein JJ, Zaltzman J, Wald R. COVID-19 Outbreak in an Urban Hemodialysis Unit. Am J Kidney Dis. 2020;76(5):690-695.e1. doi: 10.1053/j.ajkd.2020.07.001.

D’Marco L, Puchades MJ, Romero-Parra M et al. Coronavirus disease 2019 in chronic kidney disease. Clin Kidney J 2020; 13: 297–306. doi: 10.1093/ckj/sfaa104.

Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.

Ruan Q., Yang K., Wang W. et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China [published correction appears in Intensive Care Med. 2020 Apr 6;:]. Intensive Care Med. 2020; 46(5):846-848. doi: 10.1007/s00134-020-05991-x.

Richardson S., Hirsch J.S., Narasimhan M. et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area [published online ahead of print, 2020 Apr 22] [published correction appears in doi: 10.1001/jama.2020.7681]. JAMA. 2020; 323(20):2052-2059. doi:10.1001/jama.2020.6775.

Ma Y., Diao B., Lv X. et al. 2019 novel coronavirus disease in hemodialysis (HD) patients: Report from one HD center in Wuhan China. medRxiv 2020.02.24.20027201. doi: 10.1101/2020.02.24.20027201.

Rombolà G., Brunini F. COVID-19 and dialysis: why we should be worried. J Nephrol. 2020;33(3):401-403. doi:10.1007/s40620-020-00737-w.

Goicoechea M, Sánchez Cámara LA, Macías N, Muñoz de Morales A, Rojas ÁG, Bascuñana A, et al. COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain. Kidney Int. 2020;98(1):27-34. doi: 10.1016/j.kint.2020.04.031.

Xiong F, Tang H, Liu L, Tu C, Tian JB, Lei CT, et al. Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China. J Am Soc Nephrol. 2020;31(7):1387-1397. doi: 10.1681/ASN.2020030354.


Abstract views: 330
PDF Downloads: 16045
Published
2021-02-27
How to Cite
Dudar, I., Krasyuk, E., Shymova, A., Hryhorieva, Y., Malasaiev, M., Fierients, O., ShifrisІ., Savchuk, V., BurzhynskaІ., & Prusskyi, F. (2021). COVID-19 in patients with chronic kidney disease stage 5. Ukrainian Journal of Nephrology and Dialysis, (2(70), 38-47. https://doi.org/10.31450/ukrjnd.2(70).2021.05